Barclays cuts Hims PT to $35; keeps Overweight
Barclays lowered its price target for Hims to $35 from $39 while keeping an Overweight rating, according to TradeXchange Newsdesk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Barclays cuts Hims & Hers price target to $35, keeps Overweight
Barclays lowers its price target on Hims & Hers Health to $35 from $39 and keeps an Overweight rating.